在线客服: 点击这里给我发消息  新用户使用步骤:会员注册→充值→重新登入→进入资源
标题:UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast cancer and trastuzumab in the human epidermal growth factor receptor 2–positive subgroup
时间:2020-05-22 17:17:04
DOI:10.1016/j.ejca.2019.09.014
PMID:31634648
大小:1157 kb
页数:11 PAGES
下载: 点击下载
预览:

浏览器不支持嵌入PDF阅读,打开新页面在线阅读

目录:
  • UCBG 2-04: Long-term results of the PACS 04 trial evaluating adjuvant epirubicin plus docetaxel in node-positive breast can ...
    • 1. Introduction
    • 2. Patients and methods
      • 2.1. Study design
      • 2.2. Patients
      • 2.3. Treatment
      • 2.4. Assessments
      • 2.5. Statistical analysis
    • 3. Results
      • 3.1. Patients and treatment
      • 3.2. Efficacy
        • 3.2.1. Primary comparison of chemotherapy regimens
        • 3.2.2. Trastuzumab in the HER2-positive subpopulation
        • 3.2.3. Safety
    • 4. Discussion
    • Role of funding sources
    • Conflict of interest statement
    • Acknowledgements
    • References

本页内容由网络收集而来,版权归原创者所有,如有侵权请及时联系